Randomized Trialhigh evidence
Age Is an Effect Modifier of Thrombectomy Benefit in a Socioeconomically Vulnerable Stroke Population.
Annals of neurology·July 24, 2026·PMID 42498265
Why it mattersIn resource-limited settings, age may be a critical determinant of EVT efficacy, contrasting with findings from high-income countries. This challenges the assumption of uniform benefit across age groups and highlights the need for tailored patient selection in developing healthcare systems.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled